TSTIF
|
Neil Maruoka, MSc, MBA | Analyst | Canaccord Genuity Corp. (Canada...
|
TSTIF
|
Summary: TSO3 Inc. Q2 In Line: Duodenoscope...
|
TSTIF
|
remains completely intact. Significant news is that in the next cc we will...
|
TSTIF
|
Conference call was good and as expected, with the negative people remaining...
|
TSTIF
|
European Expansion Getinge continued to launch the STERIZONE VP4 Sterilizer...
|
TSTIF
|
Neil Maruoka, MSc, MBA | Analyst | Canaccord Genuity Corp. (Canada...
|
TSTIF
|
This is an excellent article. Particularly interesting are statements "...
|
TSTIF
|
TSO3 Sets Second Quarter Earnings Call for Wednesday, August 2, 2017 at 8:30...
|
TSTIF
|
With the loss of at least 4 Senators and not the votes to get a replacement...
|
TSTIF
|
One can only hope so, with the GOP no longer having the votes to bring the...
|
TSTIF
|
StocksFTB, among others, might check their SH 'inbox'? :)
|
TSTIF
|
As some of you might recall, I was very interested in the shenanigans of the...
|
TSTIF
|
It is difficult to determine which specific hospitals use a VP4 in the GTA as...
|
TSTIF
|
Summary: TSO3 Inc. Commercializing Best-in-Class...
|
TSTIF
|
The FDA document avoids the critical vs. semi-critical issue (leaving this to...
|
TSTIF
|
Agree, Cash. But, what you are referring to is the Spaulding Classification...
|
TSTIF
|
Not sure who this secret analyst might be, but the points need a reply and...
|
TSTIF
|
Another Analyst is Loving What They See from TSO3!! (And, the FDA!!! Adding...
|
TSTIF
|
I find the apparent confusion in the market regarding the significance of...
|
TSTIF
|
Previous regulation only required 'cleaning and disinfection'...
|